Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD
Objective We aimed to determine the association of statins with progression to a high risk for advanced fibrosis in primary care patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Design This retrospective cohort study of electronic health record data included patients wi...
Saved in:
Main Authors: | Andrew D Schreiner, William P Moran, Jingwen Zhang, Patrick D Mauldin, Justin Marsden, Mulugeta Gebregziabher, Chelsey A Petz, David G Koch, Chloe Bays |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/11/1/e001404.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01) -
An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01) -
Considerations for Developing Effective Herbicide Prescriptions for Forest Vegetation Management
by: Anna Osiecka, et al.
Published: (2011-06-01) -
Polymorphism of renin — angiotensin system genes in progression of liver fibrosis in patients with chronic hepatitis C
by: O. V. Taratina, et al.
Published: (2014-08-01) -
Association between statin administration and outcome in patients with sepsis: A retrospective study
by: Zhou Jianzhu, et al.
Published: (2025-02-01)